-
April 05, 2022
The Sixth Circuit on Tuesday swatted away protests from Walgreens and Walmart about "extraordinary, unusual pressure" to strike a settlement after a jury blamed them for out-of-control opioid sales, clearing the way for the first damages trial against pharmacy giants in multidistrict litigation.
-
April 04, 2022
The California federal judge overseeing an upcoming bellwether bench trial in multidistrict opioid litigation explained the strict time limits he put on the trial's testimony Monday, declaring that like Miss Piggy, "Opioid trial, c'est moi."
-
March 23, 2022
An impending bellwether trial involving San Francisco and several drug companies in multidistrict opioid litigation will be among the shortest opioid trials yet despite shaping up as one of the largest, a California federal judge said Wednesday, an admittedly startling move accompanied by other streamlining efforts.
-
March 22, 2022
Lawyers for CVS Pharmacy, Walgreens and Walmart will face discipline if they don't swiftly rectify noncompliance with a "clear and simple" directive to outline remedies after a jury blamed the companies for inundating communities with prescription narcotics, the top judge in multidistrict opioid litigation warned.
-
March 11, 2022
Despite sweeping settlements and landmark verdicts, the nation's epic saga of opioid crisis litigation against Big Pharma is far from winding down, with the coming weeks heralding an unprecedented torrent of trials. Here, Law360 shares a detailed map of the opioid trials terrain and explores major lawsuits that are rapidly approaching moments of truth.
-
March 11, 2022
The Sixth Circuit on Friday ordered the Ohio federal judge overseeing opioid multidistrict litigation to rule on remand motions from three Texas counties and two New Mexico cities, finding that the cases have been pending for an "unduly long time."
-
March 11, 2022
Roughly 40 school districts, largely in Maine, have agreed to end opioid-related claims against Johnson & Johnson following negotiations with the state attorney general to receive a cut of a $26 billion global deal struck in nationwide litigation, an attorney for the schools told Law360 Friday.
-
March 07, 2022
The Ohio federal judge overseeing multidistrict litigation over the opioid crisis on Monday refused to strike a jury verdict that held major pharmacy chains liable for fueling the crisis in two Ohio counties, finding there was sufficient evidence at trial for the jury to make its decision and rejecting a request for a new trial.
-
February 11, 2022
Tennessee counties and Endo Pharmaceuticals traded bitter claims of legal shenanigans before the drugmaker suffered another default judgment for opioid discovery misconduct, and the bombshell ruling underscores the company's ongoing peril in nationwide opioid litigation, according to court records and experts.
-
February 01, 2022
Native American tribes have agreed to a deal worth nearly $590 million with Johnson & Johnson and major opioid distributors to settle claims over the companies' alleged role in exacerbating the opioid crisis, according to court filings Tuesday.